Previous close | 6.06 |
Open | 6.06 |
Bid | 5.15 |
Ask | 7.30 |
Strike | 71.00 |
Expiry date | 2024-05-31 |
Day's range | 6.06 - 6.06 |
Contract range | N/A |
Volume | |
Open interest | 8 |
AstraZeneca is withdrawing its highly successful coronavirus vaccine, citing the availability of a plethora of new shots that has led to a decline in demand.
Ionis (IONS) posts mixed first-quarter 2024 results. The company continues to focus on pipeline development.
The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator. In an update on the European Medicines Agency's website Wednesday, the regulator said that the approval for AstraZeneca's Vaxzevria had been withdrawn “at the request of the marketing authorization holder.” AstraZeneca's COVID-19 vaccine was first given the nod by the EMA in January 2021.